Juan J. Reino-Gomez
Santiago De Compostela, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.
Journal: Rheumatology (Oxford, England)
Published: March 11, 2019
Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment.
Journal: RMD open
Published: December 20, 2018
Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment.
Journal: RMD open
Published: November 07, 2017
Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study.
Journal: The Journal of rheumatology
Published: October 21, 2016
Therapy: The NICE position on indications for biologics and biosimilars.
Journal: Nature reviews. Rheumatology
Published: April 16, 2016
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.
Journal: Annals of the rheumatic diseases
Published: March 01, 2015
Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience.
Journal: Rheumatology international
Published: April 26, 2013
Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: March 15, 2013
Variants within STAT genes reveal association with anticitrullinated protein antibody-negative rheumatoid arthritis in 2 European populations.
Journal: The Journal of rheumatology
Published: July 04, 2012
Association of anti-citrullinated vimentin and anti-citrullinated α-enolase antibodies with subsets of rheumatoid arthritis.
Journal: Arthritis and rheumatism
Published: June 08, 2012
Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis.
Journal: Arthritis and rheumatism
Published: February 23, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026